treatment
ASH 2024 Update: MDS and AML
In this webinar, Dr. Akriti Jain discusses research most relevant to patients reported over the past year on the biology and treatment on MDS and AML. These studies were presented at the American Society of Hematology (ASH) 2024 meeting and their findings will be explained along with the potential impact of this research on understanding and treating MDS and AML. This is an advanced scientific presentation.
In Treatment for PNH: Shane's Story
Shane Pope talks about living with PNH, or Paroxysmal Nocturnal Hemglobinuria, in this recorded conversation with Leigh Clark. Listen or read the transcript below.
Bharadhwaj Kolipakkam, MD
Kolipakkam, Bharadhwaj
Hematologist/Oncologist
VCU Health
Michael Jaglal, MD
Jaglal, Michael
Hematologist/Oncologist
Moffitt Cancer Center
Online Profile:
Karyn Brundige, MSN, CPNP
Brundige, Karyn
Pediatric Nurse Practitioner
Dana-Farber Cancer Institute
Online Profile:
Can JAK inhibition prevent GVHD?
In this issue of Blood, Pidala et al report on the results of a multicenter phase 2 trial, in which a
Therapy for acute myeloid leukemia in older and unfit adults
TITLE Azacitidine and venetoclax in previously untreated acute myeloid leukemia.
Allogeneic Hematopoietic Cell Transplantation for the Treatment of Severe Aplastic Anemia: Evidence-Based Guidelines From the American Society for Transplantation and Cellular Therapy
My Journey with Severe Aplastic Anemia: A Story of Hope and Resilience
Person's Name:
Eman Al Salti
Bone Marrow Disease(s):
Content source: